Expression of Lipocalin-Type Prostaglandin D Synthase in Glioma

苏兵,关明,刘维薇,吕元
DOI: https://doi.org/10.3760/j:issn:1009-9158.2003.03.009
2003-01-01
Abstract:Objective To investigate the expression level of lipocalin-type prostaglandin D synthase (L-PGDS) mRNA and its protein in glioma.Methods The L-PGDS mRNA was determined by real-time quantitative RT-PCR in 23 glioma and 5 healthy brain specimens. L-PGDS protein was detected by Western blot in cerebrospinal fluid (CSF) and brain tissue specimens.Results In 23 glioma specimens L-PGDS mRNA expression ranges from 1.5×10 3~7.0×10 4 copy/μg RNA, mean value is 1.6×10 4 copy/μg RNA. In 5 normal brain specimens, the mean value is 8.1×10 5 copy/μg RNA, statistic analysis indicates a distinct discrepancy ( P0.05), and L-PGDS mRNA expression level correlates with the histological grade of malignancy. For glioma cell line U-251 the expression level of L-PGDS mRNA is 4.7×10 3 copy/μg RNA. Western blot indicates that L-PGDS protein expression level is 0.47±0.12 in glioma and 0.92±0.26 in healthy people, statistic analysis indicates a distinct discrepancy ( P0.01).Conclusions It is found that the expression level of L-PGDS mRNA and its protein decrease in glioma. This implies that L-PGDS has a potential value for diagnosis and therapy of glioma.
What problem does this paper attempt to address?